Our Story & Mission

Vision care that reaches everyone, everywhere.

With VitaNext, world-class screening is no longer a privilege of a few but a standard of care for all.

1B+
Preventable vision-impairment cases worldwide - WHO, 2023
550M
Indians living with uncorrected poor vision - Seva Report, 2022
90%
of glaucoma cases go undetected, due to lack of testing - WHO, 2023
111M
People with glaucoma worldwide by 2040 - a near doubling - Tham et al., 2014
Eyeonic visual field test setup on laptop

Born from a gap in global eye care.

VitaNext was born out of a recognition that conventional perimetry was inaccessible to the vast majority of the population. The machines were large, expensive, and concentrated in specialist centres in high-income areas.

That's where VitaNext World with Eyeonic steps in, bringing cutting-edge global innovations to India with the mission of making eye care accessible to all.

The same team that brings you VitaNext World was the first in Northern India to set up an industry for the Italian technology of Glass Reinforced Pipe (GRP), built a 12-acre factory for the same, established 15,000 kiosks around the country for State Bank of India under Starfin (valued at ₹100 Cr by L&T Finance), provided specialised training to almost 200,000 individuals through Skillboard, and founded Unicare - offering healthcare privilege cards with discounts at medical centres and pharmacies.

Product Timeline

A decade of progress in vision care.

2019

Founded by A/Prof Skalicky

PhD in visual physiology. Status quo limitations of conventional perimetry identified - the foundation for a software-first approach to visual field testing.

2020

MVP & IP protection

Coding expertise assembled, minimum viable product developed, and intellectual property protection secured for the core technology.

2021

AI, cloud & Microsoft for Startups

AI and machine learning integrated into the platform. Accepted into Microsoft for Startups; Azure cloud deployment established as the backbone for secure, scalable delivery.

2022

Multinational research & regulatory groundwork

Multinational clinical research programmes launched. TGA and FDA regulatory requirements met; peer-reviewed papers published and industry awards received.

2023

Global registrations, leadership & commercialisation

Product registered in UK and Africa. CTO and CCO appointed. Distributors signed in South Africa and Ghana. UX/UI refinement, commercialisation strategy launched, and trial partners onboarded.

2024

FDA & TGA approvals; seed funding oversubscribed

FDA (US) and TGA (Australia) approvals secured. Expansion into UK, Africa, and India accelerates. Seed funding round oversubscribed.

2025

TGA approval, India & enterprise growth

TGA approval (Australia) finalised. Active deployment across India, ANZ, and SE Asia. Enterprise customers onboarded at scale.

2026

VitaNext and Eyeonic join hands

VitaNext comes together with Eyeonic, bringing together best-in-class technology and a national network committed to making vision care accessible to all.

Trusted by clinics & research partners worldwide

PartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartner PartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartnerPartner

Ready to bring better vision care to more patients?

Get a free trial and see how Eyeonic performs in your clinic or outreach programme.

Contact Us

Get in Touch

Form placeholder: not yet wired up. Connect to your CRM or email service to make it functional.